Arnhem, Netherlands-based drug and chemicals group Akzo Nobel has signed an agreement to divest its polymerization catalysts and components business in the USA to Basell Polyolefins, the world's largest producer of polypropylene and polyolefin products.
This is the third chemicals divestment announced by the firm in 2006 and is part of its $578.0 million realignment program. All remaining divestments are expected to be completed by the middle of the year, the company noted.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze